Erin Hunter is an assistant editor at Pharmacy Times®. She is a proud alumna of the University of Massachusetts. She graduated with degrees in Journalism, Art History, and Environmental Conservation.
Finerenone May Protect Patients With Chronic Kidney Disease From Pneumonia-Related Severe Adverse Events
The drug is a selective, nonsteroidal mineralocorticoid receptor antagonist found to also protect against COVID-19 and pneumonia-related adverse events in patients with diabetes.
A Primary Dose of ChAdOx1-S Adenovirus-based Vaccine May Increase Thrombosis
The vaccine is suggested to cause more rare cases of thrombosis with thrombocytopenia syndrome than the mRNA-based vaccine, especially among younger individuals.
5 Key Sessions at the American Society of Nephrology Kidney Week
Pharmacy Times will be covering the American Society of Nephrology (ASN) Kidney Week, which will be gathering more than 10,000 professionals working on kidney health in Orlando, Florida.
Leading Nephrologist Discusses Importance of Pharmacist Role In Kidney Care for ASN Kidney Week
Pharmacy Times is gearing up for Kidney Week (Nov. 3-6) by learning about the pharmacological role of kidney care from the president of the American Society of Nephrology.
Artificial Intelligence May Drive More Personalized Treatment Protocols
New evidence suggests that using artificial intelligence can help individualize diagnostics and protocols, including when women should get mammograms and what medications can best suit which people.
Nobiletin May Inhibit Tumor Activity in Cholangiocarcinoma
A compound often found in citrus fruits, nobiletin, could be a less toxic and more effective treatment for cholangiocarcinoma.
Aldeyra Therapeutics Plans Submission for Dry Eye Disease Treatment by End of 2022
New dry eye disease treatment on the horizon.
C-reactive Protein Score May Predict PD-1 Inhibitor Treatment Efficacy in Intrahepatic Cholangiocarcinoma
Inflammation-based prognostic scores can be a valuable tool in assessing the overall survival of patients with intrahepatic cholangiocarcinoma.
Cystatin C Levels May Accurately Stratify Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease
The estimation of glomerular filtration rate based on cystatin C could provide a more robust prediction of cardiovascular disease and mortality in patients.
Aclidinium Bromide/Formoterol, Aclidinium Bromide May Be Effective for Severe Stable COPD
Covis announced positive topline results for 2 new medications that can treat patients with moderate to severe stable chronic obstructive pulmonary disease.
Help Prevent Spread of Pink Eye
School can spread more than knowledge- some researchers suggest that pink eye is most commonly spread among school students.
Overall Cancer Death Rates Have Declined, But Rates Among Racial/Ethnic Minorities Have Not Followed Suit
By 2019, lung cancer mortality rates decreased by 5.4% in males since 2015, while deaths from ovary cancer have also declined rapidly over the past 2 decades.
Investigators Suggest Conjunctivitis May Transmit Monkeypox
Monkeypox may be transmitted through conjunctivitis, according to a new study.
Interim FDG-PET/CT May Have Positive Prognostic Value for Hodgkin’s Lymphoma
Research suggests that positron emission tomography scans are effective at detecting early and late Hodgkin’s lymphoma, and the results could help manage and reduce toxicity from current chemotherapies.
Next-Generation Approaches to Overcoming Drug Resistance in Therapies Multiple Myeloma
Understanding the novel mechanisms of multiple myeloma can help to develop better next-generation therapies that overcome drug resistance.
Carboplatin Should Be Favored Over Cisplatin for Small Cell Lung Cancer Treatment Due to Toxicity Profile
In a multivariable analysis, treatment with carboplatin is favored for extensive-stage cell lung cancer, even if it is not found to increase overall survival compared to standard care.
Supplementation With Lower Oxygen May Not Worsen Mortality Risk In Patients With Hypoxic-Ischemic Brain Injury
In patients with hypoxic-ischemic brain injury, researchers observed no significant difference between liberal and restrictive oxygenation on any-cause death.
The mRNA-1273 Vaccine at 25-μg Dosage May Protect Infants, Young Children Against Omicron
The Moderna mRNA-1273 vaccine was found to be effective for more than 50% of children aged 6 to 23 months.
October Generic Focus
Bacterium in the Gut Could be a Biomarker to Predict the Severity of COVID-19 Symptoms
A researcher suggests that the levels of certain gut bacteria can predict the severity of symptoms that someone can experience when infected with COVID-19.
Previous Non-Omicron SARS-CoV-2 Infection May Protect Against Infection of Omicron
Prior infection with SARS-CoV-2 decreased the risk of being reinfected with Omicron among unvaccinated and vaccinated individuals.
Study: Health Care Providers May Perpetuate Racial Disparities in Heart Failure Treatment
Black adults are suggested to have an increased risk of heart failure, which highlights the need for equitable treatment and decision-making.
Influenza Gene Interactions May Help Researchers Accurately Predict Dominant Strains
Understanding the relationship between viral protein activity and rapid gene mutations could help researchers save more lives by creating a more effective flu vaccine.
Central Nervous System Infection Is Common in Multiple Strains of Herpesvirus
Researchers conducted a review all 8 herpesviruses and their known treatments and found patients experienced encephalitis or another CNS symptom in almost every strain.
Study: Relaxation of Public Health Interventions for COVID-19 Has Strongest Impact on Children Aged 1 to 4 Years
Researchers suggest that winter 2020 to 2021 public health interventions lowered natural immunity in children and put them at greater risk of respiratory infection after restrictions were lifted.
Nivolumab Could Increase Rate of Recurrence Free Survival By More Than 90% In Patients With Resected Stage 2B Melanoma
Nivolumab may cut the risk of death or recurrent cancer by more than half, according to phase 3 trial results.
Risk of Developing Severe Breakthrough Infection From COVID-19 May Increase Over 50 Years of Age
The risk of severe COVID-19 breakthrough infection was stronger with age and some comorbidities—the findings can inform antiviral distribution to prevent death or respiratory failure.
“If It Can't Kill, It’s Not Effective.” How Understanding T-cell Exhaustion Can Improve CAR T-cell Therapy
CAR T cells may have the ability to be engineered and remain consistently functional, leading to more effective cancer treatment.
Express Scripts’ Contract With Department of Defense May Limit Access to Lifesaving Medication for Tricare Patients
NCPA will appeal Express Scripts’ decision to reduce access to medications, following a contract with the Department of Defense.
High Levels of Biomarker suPAR May Predict Risk of Heart Failure, Death
New research suggests that high levels of an immune protein in kidney disease might be able to predict risk of heart failure or death by reflecting the upstream process of stress.
2 Clarke Drive Cranbury, NJ 08512